[1]杨 琛,殷思雨,张春妮.糖化低密度脂蛋白与糖尿病患者动脉粥样硬化的相关研究[J].医学研究与战创伤救治(原医学研究生学报),2013,15(03):269-272.[doi:10.3969/j.issn.1672-271X.2013.03.020]

点击复制

糖化低密度脂蛋白与糖尿病患者动脉粥样硬化的相关研究()

分享到62.8K

参考文献/References:

[1] Garcia MJ,McNamara PM,Gordon T,et al.Morbidity and mortality in diabetics in the framingham population,sixteen year follow-up study [J].Diabetes,1974,23(2):105-111. [2] Low H,Hoang A,Forbes J,et al.Advanced glycation end-products(AGEs)and functiona-lity of reverse cholesterol transport in patients with type 2 diabetes and in mouse models [J].Diabetologia,2012,55(9):2513-2521. [3] 王 黎,金 晖,孙子林,等.糖基化终产物对小鼠巨噬细胞基质金属蛋白酶诱导物表达、分泌及基质金属蛋白酶9活性的影响[J].中国动脉硬化杂志,2009,17(4):289-293. [4] Sasaki N,Toki S,Chowei H,et al.Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease [J].Brain Res,2001,888(2):256-262. [5] Hein G,Weiss C,Lehmann G,et al.Advanced glycation end product modification of bone proteins and bone remodelling:hypothesis and preliminary immunohistochemical findings [J].Ann Rheum Dis,2006,65(1):101-104. [6] Assimakopoulos D,Danielides V,Kontogianis N,et al.Sudden hearing loss as the presenting symptom of diabetes mellitus [J].Diabetes Res Clin Pract,2001,53(3):201-203. [7] Howes KA,Liu Y,Dunaief JL,et al.Receptor for advanced glycation end products and age-related macular degeneration [J].Invest Ophthalmol Vis Sci,2004,45(10):3713-3720. [8] Gebhardt C,Riehl A,Durchdewald M,et al.RAGE signaling sustains inflammation and promotes tumor development [J].J Exp Med,2008,205(2):275-285. [9] Allmen EU,Koch M,Fritz G,et al.V domain of RAGE interacts with AGEs on prostate carcinoma cells [J].Prostate,2008,68(7):748-758. [10] Brown BE,Mahroof FM,Cook NL,et al.Hydrazine compounds inhibit glycation of low-density lipoproteins and prevent the in vitro formation of model foam cells from glycolaldehyde-modified low-density lipoproteins [J].Diabetologia,2006,49(4):775-783. [11] Umudum F,Yucel O,Sahin Y,et al.Erythrocyte membrane glycation and Na(+)–K(-)levels in NIDDM [J].J Diabetes Complications,2002,16(5):359-362. [12] Knott HM,Brown BE,Davies MJ,et al.Glycation and glycoxidation of low-density lipoproteins by glucose and low-molecular mass aldehydes.formation of modified and oxidized particles [J].Eur J Biochem,2003,270(17):3572-3582. [13] Brown BE,Dean RT,Davies MJ.Glycation of low-density lipoproteins by methylglyoxal and glycolaldehyde gives rise to the in vitro formation of lipid-laden cells [J].Diabetologia,2005,48(2):361-369. [14] 刘爱华,谢淑萍,王拥军.糖化低密度脂蛋白与颈动脉粥样硬化的关系研究[J].中华老年心脑血管病杂志,1999,1(1):23-26. [15] 韩 萍,郭津津.血浆糖化低密度脂蛋白,脂蛋白(a)与2型糖尿病大血管病变的关系[J].中国糖尿病杂志,2000,8(1):30-32. [16] Stitt AW,He C,Friedman S,et al.Elevated AGE-modified apoB in sera of euglycemic,normolipidemic patients with atherosclerosis:relationship to tissue AGEs [J].Mol Med,1997,3(9):617-627. [17] Chang JB,Chu NF,Syu JT,et al.Advanced glycation end products(AGEs)in relation to atherosclerotic lipid profiles in middle-aged and elderly diabetic patient [J].Lipids Health Dis,2011,10:228. [18] Younis N,Charlton-Menys V,Sharma R,et al.Glycation of LDL in non-diabetic people:small dense LDL is preferentially glycated both in vivo and in vitro [J].Atherosclerosis,2009,202(1):162-168. [19] Ichiki T,Funako shi Y,Ito K,et al.Expression of monocyte chemoattractant protein 21 by nonenzymatically glycated album in(Amadori adducts)in vascular smooth muscle cells [J].Biochem Biophys Res Commun,2000,269(3):666-670. [20] Wang Z,Jiang Y,Liu N,et al.Advanced glycation end-product nε-carboxymethyl-lysine accelerates progression of atherosclerotic calcification in diabetes [J].Atherosclerosis,2012,221(2):387-396. [21] Sobal G,Menzel J,Sinzinger H.Why is glycated LDL more sensitive to oxidation than native LDL?A comparative study [J].Prostaglandins Leukot Essent Fatty Acids,2000,63(4):177-186. [22] Rashid I,van Reyk DM,Davies MJ.Carnosine and its constituents inhibit glycation of low-density lipoproteins that promotes foam cell formation in vitro [J].FEBS Lett,2007,581(5):1067-1070. [23] Shiu SW,Wong Y,Tan KC.Effect of advanced glycation end products on lectin-like oxidized low density lipoprotein receptor-1 expression in endothelial cells [J].J Atheroscler Thromb,2012,19(12):1083-1092. [24] Ravandi A,Kuksis A,Shaikh NA.Glycated phosphatidylethanolamine promotes macrophage up take of low density lipoprotein and accumulation of cholesterylesters and triacylglycerols [J ].J Biol Chem,1999,274(23):16494-16500. [25] De Nigris F,Rienzo M,Sessa M.et al.Glycoxydation promotes vascular damage via MAPK-ERK /JNK pathways [J].J Cell Physiol,2012,227(11):3639-3647. [26] Soran H,Durrington PN.Susceptibility of LDL and its subfractions to glycation [J].Curr Opin Lipidol,2011,22(4):254-61. [27] Akanji AO,Abdella N,Mojiminiyi OA.Determinants of glycated LDL levels in nondiabetic and diabetic hyperlipidaemic patients in Kuwait [J].Clin Chim Acta,2002,317(1-2):171-176. [28] Wautier JL,Guillausseau PJ.Advanced glycation end productstheir receptors and diabetic angiopathy [J].Diabetes Metab,2001,27(5 Pt 1):535-542. [29] R Singh,A Barden,T Mori,et al.Advanced glycation end-products:a review [J].Diabetologia,2001,44(2):129-146. [30] Brownlee M,Cerami A,Vlassara H.Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications [J].N Engl J Med,1988,318(20):1315-1321. [31] Riccardo Candido,Michela Zanetti.Current perspective.Diabetic vascular disease:from endothelial dysfunction to atherosclerosis [J].Ital Heart J,2005,6(9):703-720. [32] Younis NN,Soran H,Sharma R,et al.Small-dense LDL and LDL glycation in metabolic yndrome and in statin-treated and non-statin-treated type 2 diabetes [J].Diab Vasc Dis Res,2010,7(4):289-295. [33] 秦 娴,杨政杰,全文超,等.阿托伐他汀治疗冠心病临床观察[J].临床合理用药,2012,5(1B):54. [34] 叶 瑛,贾 楠.瑞舒伐他汀的临床研究进展[J].中国新药与临床杂志,2010,29(11):813-816. [35] Zimmermann R,Panzenbock U,Wintersperger A,et al.Lipoprotein lipase mediates the uptake of glycated LDL in fibroblasts,endothelial cells,and macrophages [J].Diabetes,2001,50(7):1643-1653. [36] Gambino R,Uberti B,Alemanno N,et al.In vivo oxidizability of LDL in type 2 diabetic patients in good and poor glycemic control [J].Atherosclerosis,2004,173(1):103-107.(收稿日期:2013-01-11)

相似文献/References: